Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse
- PMID: 26488814
- DOI: 10.1016/j.immuni.2015.10.004
Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse
Abstract
Predicting cancer patients' response to therapy is essential for curing disease and improving quality of life. Garraway and colleagues demonstrate that the frequency and number of neoantigens, non-synonymous mutations, and adaptive immune genes, but not the assessment of individual recurrent neoantigens or mutations, predicts patient responses to immunotherapy.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment on
-
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10. Science. 2015. PMID: 26359337 Free PMC article.
Similar articles
-
CANCER. The odds of immunotherapy success.Science. 2015 Oct 9;350(6257):158-9. doi: 10.1126/science.aad4140. Science. 2015. PMID: 26450194 No abstract available.
-
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10. Science. 2015. PMID: 26359337 Free PMC article.
-
Somatic mutations and immunotherapy outcome with CTLA-4 blockade in melanoma.N Engl J Med. 2014 Dec 4;371(23):2230-2. doi: 10.1056/NEJMe1413061. Epub 2014 Nov 19. N Engl J Med. 2014. PMID: 25409261 Free PMC article. No abstract available.
-
Targeted therapies for metastatic melanoma.Dermatol Clin. 2012 Jul;30(3):517-24. doi: 10.1016/j.det.2012.05.001. Dermatol Clin. 2012. PMID: 22800555 Review.
-
[Adverse effects of immune checkpoint inhibitors used to treat melanoma and other cancer].Presse Med. 2017 Sep;46(9):808-817. doi: 10.1016/j.lpm.2017.05.032. Epub 2017 Jul 3. Presse Med. 2017. PMID: 28683958 Review. French.
Cited by
-
Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses.Front Genet. 2022 Nov 3;13:959170. doi: 10.3389/fgene.2022.959170. eCollection 2022. Front Genet. 2022. PMID: 36406121 Free PMC article.
-
Dissecting the Immune Landscape of Acute Myeloid Leukemia.Biomedicines. 2018 Nov 25;6(4):110. doi: 10.3390/biomedicines6040110. Biomedicines. 2018. PMID: 30477280 Free PMC article. Review.
-
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.Immunity. 2017 Aug 15;47(2):284-297.e5. doi: 10.1016/j.immuni.2017.07.020. Immunity. 2017. PMID: 28813659 Free PMC article.
-
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecan.Cell Rep Med. 2025 Jul 15;6(7):102201. doi: 10.1016/j.xcrm.2025.102201. Epub 2025 Jun 24. Cell Rep Med. 2025. PMID: 40562041 Free PMC article. Clinical Trial.
-
Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.ACS Nano. 2018 Feb 27;12(2):1250-1261. doi: 10.1021/acsnano.7b07384. Epub 2018 Jan 31. ACS Nano. 2018. PMID: 29370526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical